Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Directorate Change

21 Dec 2011 07:00

RNS Number : 3615U
Cello Group plc
21 December 2011
 



21 December 2011

 

Cello Group plc

 

Directorship change

 

Cello Group plc (AIM: CLL, "Cello" or "the Group"), the insight and strategic marketing group, announces the retirement of Paul Walton from the Board effective as at 31 December 2011.

 

Paul founded The Value Engineers, a core Cello business, over 25 years ago and established the business as a highly respected advisor to global brand owners on strategic marketing issues. Over the past six years, Paul has successfully facilitated the transition of The Value Engineers to the current management team.

 

More recently as a director, Paul has led the brand repositioning of Cello, and the embedding of the partnership philosophy that underpins the professional structure of the group. These tasks now being complete, Paul is stepping back from a full time role.

 

Following his retirement from the board, Paul will remain a highly valued advisor to the company on a part time basis with a special remit for the highly regarded Cello Academy.

 

 

Mark Scott, CEO of Cello, commented;

 

"The Board and senior management team of Cello wish to thank Paul for his great contribution to the success of the company. He has helped transform Cello into a vibrant community of motivated professionals. He has been a great source of inspiration to many of us and we look forward to his continued engagement with the future of the company."

 

 

Enquiries:

 

Cello Group plc (www.cellogroup.co.uk)

Mark Scott, Chief Executive

020 7812 8460

Mark Bentley, Group Finance Director

Cenkos

Bobbie Hilliam / Stephen Keys

020 7397 8900

College Hill

Kay Larsen / Rozi Morris

020 7457 2020

 

 

Notes to Editors (www.cellogroup.co.uk)

 

Cello is an insight and strategic marketing group.

 

The Group's strategy is to create value for shareholders by building an international research and consulting business able to advice blue chip clients globally, along with a marketing business capable of delivering world class solutions.

 

Cello has annualised revenues in excess of ÂŁ130m, annualised gross profit in excess of ÂŁ65m and employs over 700 professional staff.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFMSFFSESE
Date   Source Headline
11th Aug 20201:38 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202012:05 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202011:34 amRNSForm 8.3 - [Cello Health plc]
11th Aug 202010:07 amRNSScheme of Arrangement becomes Effective
11th Aug 20208:49 amPRNForm 8.3 - Cello Health Plc
11th Aug 20207:30 amRNSSuspension - Cello Health Plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 202012:12 pmRNSRelevant Securities in Issue
10th Aug 202011:02 amRNSForm 8.3 - Cello Health PLC
10th Aug 20208:54 amRNSExercise of Options
10th Aug 20208:06 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Aug 20203:04 pmRNSCourt Sanction of Scheme
7th Aug 202012:52 pmRNSAdditional Block Listing of Ordinary Shares
6th Aug 202011:01 amRNSForm 8.3 - Cello Health PLC
5th Aug 20201:34 pmRNSForm 8.3 - Cello Health Plc
4th Aug 20205:30 pmRNSCello Health
4th Aug 202012:39 pmRNSForm 8.3 - Cello Health PLC
4th Aug 20208:21 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202012:57 pmRNSResults of Court Meeting and General Meeting
3rd Aug 202010:53 amRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202012:39 pmRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202011:46 amRNSForm 8.3 - Cello Health PLC
31st Jul 20208:34 amRNSForm 8.5 (EPT/NON-RI)
31st Jul 20207:58 amRNSForm 8.3 - Cello Health PLC
30th Jul 20205:11 pmRNSHolding(s) in Company
30th Jul 20208:03 amRNSForm 8.3 - Cello Health Plc
29th Jul 202012:49 pmRNSHolding(s) in Company
29th Jul 20208:30 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20206:18 pmRNSUpdate on letters of intent
28th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
28th Jul 20202:46 pmRNSForm 8.3 - Cello Health PLC
28th Jul 20202:04 pmRNSNotification of Major Holdings
28th Jul 20201:24 pmRNSCELLO HEALTH PLC ORD GBP0.10
28th Jul 202011:36 amGNWForm 8.3 - [Cello Health plc] - (HHL)
28th Jul 202011:17 amRNSForm 8.3 - Cello Health Plc
28th Jul 20208:45 amRNSForm 8.5 (EPT/NON-RI)
27th Jul 20203:17 pmRNSForm 8.3 - [CELLO HEALTH PLC
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20203:29 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202012:33 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202011:38 amRNSFORM 8.3 - Cello Health Plc
21st Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
21st Jul 20202:35 pmRNSForm 8.3 - Cello Health PLC
21st Jul 202012:18 pmRNSBlock Listing Update & Total Voting Rights
21st Jul 20207:00 amRNSHolding(s) in Company
20th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.